Tag Archives: biosensors

Start using electronic data capture in clinical trials

A recent publication suggests that Electronic Data Capture systems, or EDCs, should be implemented in clinical trials. The EDC software can reduce the overall trial costs by an estimated $347,600 in a phase ll trial of 20 sites, 10 patients per site and a duration of 12 months plus data cleaning. See the table.


Table: Forrester Research Paper versus EDC cost comparison.

In this example, monitor visits still costs $ 180,000. Vitaphone CTS provides solutions to make subjects monitor their vital signs at home. This can also enhance their trial compliance. Re-activity is a top priority to create better and more efficient clinical trials. The tools developed by Vitaphone CTS will send biosensor data immediately and thus ensure almost real-time data. Our medication adherence support system (MASS) stimulates the study subjects to take their study medication.

Remote monitoring and support enables pharmaceutical, biotechnology and medical device industries to focus on the development of the best drug or device.

Using telemonitoring solutions, investigators can improve patient safety. This might be achieved through faster notification of adverse events to the Principal Investigator, CRO or Sponsor. This will support earlier and better decision-making. Embrace technology.

Author: Indy Kavelaars

Source: Clinovo


Tagged , , , , ,

Texting could be good for your health

Imagine: you have a medical problem and know why this problem exists. Next thing is that you receive a text message on a (very) frequent way to tell you (again) what is wrong with you. I think my participation wouldn’t last very long. Ah…that’s what they also found in a Detroit and Cincinnati study: only 39% stuck through 14 (!) weeks. But OK; this part of the test population learned more about their health situation. No idea if that did something with their health status.

What if this text message service was integrated with additional services, like telemonitoring with biosensors, bi-directional contact with caregiver, medication adherence support and personal attention? This should lead to impressive results! Technology is there…who will be first?

Auteur: Rene Stenvert @ Vitaphone Netherlands

Source: Uofm Health

Tagged , ,
%d bloggers like this: